...
首页> 外文期刊>Clinical Science >Activation of intracellular angiotensin AT(2) receptors induces rapid cell death in human uterine leiomyosarcoma cells
【24h】

Activation of intracellular angiotensin AT(2) receptors induces rapid cell death in human uterine leiomyosarcoma cells

机译:细胞内血管紧张素AT(2)受体的激活诱导人子宫平滑肌肉瘤细胞快速细胞死亡。

获取原文
获取原文并翻译 | 示例

摘要

The presence of angiotensin type 2 (AT(2)) receptors in mitochondria and their role in NO generation and cell aging were recently demonstrated in various human and mouse non-tumour cells. We investigated the intracellular distribution of AT(2) receptors including their presence in mitochondria and their role in the induction of apoptosis and cell death in cultured human uterine leiomyosarcoma (SK-UT-1) cells and control human uterine smooth muscle cells (HutSMC). The intracellular levels of the AT(2) receptor are low in proliferating SK-UT-1 cells but the receptor is substantially up-regulated in quiescent SK-UT-1 cells with high densities in mitochondria. Activation of the cell membrane AT(2) receptors by a concomitant treatment with angiotensin II and the AT(1) receptor antagonist, losartan, induces apoptosis but does not affect the rate of cell death. We demonstrate for the first time that the high-affinity, non-peptide AT(2) receptor agonist, Compound 21 (C21), penetrates the cell membrane of quiescent SK-UT-1 cells, activates intracellular AT2 receptors and induces rapid cell death; approximately 70% of cells died within 24 h. The cells, which escaped cell death, displayed activation of the mitochondrial apoptotic pathway, i.e. down-regulation of the Bcl-2 protein, induction of the Bax protein and activation of caspase-3. All quiescent SK-UT-1 cells died within 5 days after treatment with a single dose of C21. C21 was devoid of cytotoxic effects in proliferating SK-UT-1 cells and in quiescent HutSMC. Our results point to a new, unique approach enabling the elimination non-cycling uterine leiomyosarcoma cells providing that they over-express the AT(2) receptor.
机译:线粒体中血管紧张素2型(AT(2))受体的存在及其在NO生成和细胞衰老中的作用最近在各种人类和小鼠非肿瘤细胞中得到证实。我们调查了AT(2)受体的细胞内分布,包括它们在线粒体中的存在及其在培养的人子宫平滑肌肉瘤(SK-UT-1)细胞和对照人子宫平滑肌细胞(HutSMC)中诱导凋亡和细胞死亡的作用。 。在增殖的SK-UT-1细胞中,AT(2)受体的细胞内水平较低,但在线粒体中具有高密度的静态SK-UT-1细胞中,该受体基本上上调。通过与血管紧张素II和AT(1)受体拮抗剂洛沙坦的联合治疗激活细胞膜AT(2)受体诱导细胞凋亡,但不影响细胞死亡率。我们首次证明高亲和力的非肽AT(2)受体激动剂化合物21(C21)穿透静止的SK-UT-1细胞的细胞膜,激活细胞内AT2受体并诱导快速细胞死亡;约70%的细胞在24小时内死亡。逃脱细胞死亡的细胞表现出线粒体凋亡途径的激活,即Bcl-2蛋白的下调,Bax蛋白的诱导和caspase-3的激活。用单剂量的C21治疗后,所有静态SK-UT-1细胞均在5天内死亡。 C21在增殖的SK-UT-1细胞和静止的HutSMC中没有细胞毒性作用。我们的结果指出了一种新的,独特的方法,该方法可以消除非循环子宫平滑肌肉瘤细胞,前提是它们过表达AT(2)受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号